• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

5
2
2
2
1

COUNTRY

2

CATEGORIES

  • 15
  • 6
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

20
21
22
28

PUBLISHED

0
2
10
28

PRODUCT TYPE

19
9

Search "Par Pharmaceutical Companies, Inc. - SWOT Analysis" returned 28 results.

PRODUCT TITLE

Par Pharmaceutical Companies, Inc. - Strategic SWOT Analysis Review

Par Pharmaceutical Companies, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains...

July 2014
FROM
Par Pharmaceutical Companies Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis Par Pharmaceutical Companies Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis - Product Thumbnail Image

Par Pharmaceutical Companies Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Par Pharmaceutical Companies Inc. Company Profile” is a comprehensive report on Par Pharmaceutical Companies Inc.. The report provides complete information on the operations, organization structure...

October 2013
FROM
Par Pharmaceutical Companies, Inc. (PRX) - Financial and Strategic SWOT Analysis Review Par Pharmaceutical Companies, Inc. (PRX) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Par Pharmaceutical Companies, Inc. (PRX) - Financial and Strategic SWOT Analysis Review

Par Pharmaceutical Companies, Inc. (PRX) - Financial and Strategic SWOT Analysis Review Summary Par Pharmaceutical Companies, Inc. (Par Pharmaceutical) is a publicly traded pharmaceutical company....

March 2012
FROM
Par Pharmaceutical Companies, Inc.: Company Profile and SWOT Analysis Par Pharmaceutical Companies, Inc.: Company Profile and SWOT Analysis - Product Thumbnail Image

Par Pharmaceutical Companies, Inc.: Company Profile and SWOT Analysis

Synopsis ICD Research's "Par Pharmaceutical Companies, Inc.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company...

December 2011
FROM
Par Pharmaceutical Companies, Inc.: SWOT Analysis & Company Profile Par Pharmaceutical Companies, Inc.: SWOT Analysis & Company Profile - Product Thumbnail Image

Par Pharmaceutical Companies, Inc.: SWOT Analysis & Company Profile

Synopsis Business Review’s Par Pharmaceutical Companies, Inc. contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company. Summary This...

April 2010
FROM

Par Pharmaceutical Companies, Inc. - SWOT, Strategy and Corporate Finance Report

Par Pharmaceutical Companies, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT...

October 2013
FROM
Par Pharmaceutical Companies, Inc.: Pharmaceuticals and Healthcare - Company Profile and SWOT Report Par Pharmaceutical Companies, Inc.: Pharmaceuticals and Healthcare - Company Profile and SWOT Report - Product Thumbnail Image

Par Pharmaceutical Companies, Inc.: Pharmaceuticals and Healthcare - Company Profile and SWOT Report

Synopsis ICD Research's "Par Pharmaceutical Companies, Inc.: Pharmaceuticals and Healthcare - Company Profile and SWOT Report" contains in depth information and data about the company and its operations....

April 2013
FROM

Auxilium Pharmaceuticals, Inc. (AUXL) - Financial and Strategic SWOT Analysis Review

Auxilium Pharmaceuticals, Inc. (AUXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been...

April 2014
FROM

Catalyst Pharmaceutical Partners, Inc. (CPRX) - Financial and Strategic SWOT Analysis Review

Catalyst Pharmaceutical Partners, Inc. (CPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile...

April 2014
FROM

Savient Pharmaceuticals, Inc. (SVNT) - Financial and Strategic SWOT Analysis Review

Summary Savient Pharmaceuticals, Inc. (Savient) is a specialty biopharmaceutical company. Its product portfolio includes KRYSTEXXA, Oxandrin and oxandrolone. Oxandrin is an oral synthetic derivative...

May 2013
FROM
KV Pharmaceutical Company (KV.A) - Financial and Strategic SWOT Analysis Review KV Pharmaceutical Company (KV.A) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

KV Pharmaceutical Company (KV.A) - Financial and Strategic SWOT Analysis Review

KV Pharmaceutical Company (KV.A) - Financial and Strategic SWOT Analysis Review Summary KV Pharmaceutical Company (KV Pharmaceutical) is a specialty pharmaceutical company engaged in the development,...

September 2011
FROM

Mylan Inc. (MYL) - Financial and Strategic SWOT Analysis Review

Mylan Inc. (MYL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

May 2014
FROM
The Top 10 Generics Companies: Strategic Insight, Growth Opportunities and Competitive Dynamics in the US and Europe The Top 10 Generics Companies: Strategic Insight, Growth Opportunities and Competitive Dynamics in the US and Europe - Product Thumbnail Image

The Top 10 Generics Companies: Strategic Insight, Growth Opportunities and Competitive Dynamics in the US and Europe

The generics sector has grown at a fast pace over the past few years, outperforming the pharmaceutical market as a whole; generic growth opportunities are significant, with an estimated $100bn worth...

March 2006
FROM

Lannett Company, Inc. (LCI) - Financial and Strategic SWOT Analysis Review

Lannett Company, Inc. (LCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

January 2014
FROM
Par Pharmaceutical Companies, Inc. - Company PicShot Par Pharmaceutical Companies, Inc. - Company PicShot - Product Thumbnail Image

Par Pharmaceutical Companies, Inc. - Company PicShot

This Company PicShot is a brief, yet detailed, profile of the chosen company. The PicShot profiles the company in terms of historical background, company overview, business segment analysis, a view...

November 2010
FROM

Columbia Laboratories Inc. (CBRX) - Financial and Strategic SWOT Analysis Review

Columbia Laboratories Inc. (CBRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM

Santarus, Inc. (SNTS) - Financial and Strategic SWOT Analysis Review

Summary Santarus, Inc. (Santarus) is a specialty biopharmaceutical company. It acquires, develops and commercializing pharmaceutical products. The company’s marketed products consists of Uceris (budesonide)...

March 2013
FROM
King Pharmaceuticals, Inc. (KG) - Financial and Strategic SWOT Analysis Review King Pharmaceuticals, Inc. (KG) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

King Pharmaceuticals, Inc. (KG) - Financial and Strategic SWOT Analysis Review

King Pharmaceuticals, Inc. (KG) - Financial and Strategic SWOT Analysis Review Summary King Pharmaceuticals, Inc. (King) is a pharmaceutical company engaged in the development and commercialization...

May 2011
FROM

Aptamers Market Technology Trend Analysis - Global Forecasts to 2018

Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global...

July 2013
FROM
Tamir Biotechnology, Inc. (ACEL) - Financial and Strategic SWOT Analysis Review Tamir Biotechnology, Inc. (ACEL) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Tamir Biotechnology, Inc. (ACEL) - Financial and Strategic SWOT Analysis Review

Tamir Biotechnology, Inc. (ACEL) - Financial and Strategic SWOT Analysis Review Summary Tamir Biotechnology, Inc. (formerly known as Alfacell Corporation) is a biopharmaceutical company engaged in...

September 2011
FROM
Loading Indicator